Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-22

Clinical Trial Update: EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection [Phase 2]

View source ↗

Summary

Phase 2 trial comparing EVPOME versus AlloDerm for reconstruction after large mandibular resection was terminated. The study status is TERMINATED on ClinicalTri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AlloDerm (acellular dermal matrix)
  • EVPOME

Snippet

Sponsor: Stephen E. Feinberg | Conditions: Mandibular Injuries | Phase 2 | Status: TERMINATED